Cytion is a global innovator in the field of biotechnology, providing premium stem cell solutions for researchers and clinicians focused on regenerative medicine and advanced biological studies. Their product portfolio features human mesenchymal stem cells (hMSCs) derived from a variety of sources, such as bone marrow, umbilical cord, and adipose tissue, designed to support applications in disease modeling, drug development, and cellular therapies.

The company is committed to ethical practices, sourcing all materials with informed donor consent and adhering to strict international guidelines. With rigorous quality control processes, Cytion ensures high cell viability and purity, employing advanced cryopreservation and marker analysis technologies to meet the evolving needs of the scientific community.